Study of Efficacy and Safety of LEE011 in Men and Postmenopausal Women With Advanced Breast Cancer.
Clinical trial NCT02422615 · COMPLETED
Trial details
- NCT number
- NCT02422615
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-09
- Primary completion
- 2017-11-03
- Enrollment
- 726
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.